EDGAR Filing Documents for 0000950170-22-006032

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0000950170-22-006032

Filing Date

2022-04-25

Accepted

2022-04-22 19:58:55

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	stro-defa14a-2022.htm	DEFA14A	17377
2	GRAPHIC	img236237016_0.jpg	GRAPHIC	479026
3	GRAPHIC	img236237016_1.jpg	GRAPHIC	330213
	Complete submission text file	0000950170-22-006032.txt		1132954

Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080

Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412

SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38662 | Film No.: 22847079
SIC: 2836 Biological Products, (No Diagnostic Substances)